NCT02154672View on ClinicalTrials.gov

Prostate Cancer Screening in Men With Germline BRCA2 Mutations

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions

Prostate Cancer

Trial Locations (1)

06520

Yale University, New Haven

All Listed Sponsors

lead

Yale University

OTHER

NCT02154672 - Prostate Cancer Screening in Men With Germline BRCA2 Mutations | Biotech Hunter | Biotech Hunter